Scholar Rock Holding (SRRK) Other financing activities (2018 - 2026)
Scholar Rock Holding (SRRK) posted quarterly Other financing activities of $3.5 million for Q1 2026, down 30.82% year-over-year from $5.0 million in Q1 2025, and down 85.41% quarter-over-quarter from $23.8 million in Q4 2025.
Scholar Rock Holding (SRRK) Other financing activities (2018 - 2026) Analysis & Trends
Scholar Rock Holding's Other financing activities history runs 9 years deep, the most recent figure standing at $3.5 million for Q1 2026.
- In Q1 2026, Other financing activities fell 30.82% year-over-year to $3.5 million; the TTM figure through Mar 2026 stood at $22.3 million (up 56.5% YoY), while the FY2025 annual figure was $23.8 million, up 147.39% from the prior year.
- Other financing activities for Q1 2026 stood at $3.5 million, down from $23.8 million in the prior quarter.
- The five-year high for Other financing activities was $23.8 million in Q4 2025, with the low at -$3.4 million in Q3 2025.
- The 5-year median for Other financing activities is $419000.0 (2024), against an average of $2.7 million.
- The sharpest annual moves came in 2024 and 2025: Other financing activities jumped 568600.0% in 2024, then tumbled 129.07% in 2025.
- Scholar Rock Holding's Other financing activities stood at $5000.0 in 2022, then soared by 69100.0% to $3.5 million in 2023, then advanced by 1.71% to $3.5 million in 2024, then jumped by 576.58% to $23.8 million in 2025, then tumbled by 85.41% to $3.5 million in 2026.
- Business Quant data shows SRRK's Other financing activities at $3.5 million in Q1 2026, $23.8 million in Q4 2025, and -$3.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Scholar Rock Holding | 6.39 Bn | 6.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.35 Mn |
| Jun 30, 2026 | 13.35 Mn |
| Mar 31, 2026 | 3.47 Mn |
| Mar 31, 2026 | 3.47 Mn |
| Dec 31, 2025 | 23.81 Mn |
| Dec 31, 2025 | 23.81 Mn |
| Sep 30, 2025 | -3.37 Mn |
| Sep 30, 2025 | -3.37 Mn |
| Jun 30, 2025 | -1.65 Mn |
| Jun 30, 2025 | -1.65 Mn |
| Mar 31, 2025 | 5.02 Mn |
| Mar 31, 2025 | 5.02 Mn |
| Dec 31, 2024 | 3.52 Mn |
| Dec 31, 2024 | 3.52 Mn |
| Jun 30, 2024 | 5.69 Mn |
| Jun 30, 2024 | 5.69 Mn |
| Mar 31, 2024 | 419,000.00 |
| Mar 31, 2024 | 419,000.00 |
| Dec 31, 2023 | 3.46 Mn |
| Dec 31, 2023 | 3.46 Mn |